| Levothyroxine sodium |
II-13630/22.06.2006 |
EUTHYROX, Tablet, 0.05, mg, Pack: 100 |
Merck KGaA, Германия |
Merck KGaA |
2.46 |
0.49 |
2.95 |
7% |
0.17 |
2.63 |
0.53 |
3.16 |
20% |
0.49 |
3.12 |
0.62 |
3.74 |
Цената се заличава с решение НСР-4001/30.06.2014 ( в сила от 02.08.2014) |
КЦ-680/06.03.2009 |
24.03.2009 |
24.03.2009 |
Заличен |
629 |
| Levothyroxine sodium |
II-13629/22.06.2006 |
EUTHYROX, Tablet, 0.025, mg, Pack: 100 |
Merck KGaA, Германия |
Merck KGaA |
2.93 |
0.59 |
3.52 |
9% |
0.26 |
3.19 |
0.64 |
3.83 |
22% |
0.64 |
3.83 |
0.77 |
4.6 |
|
КЦ-680/06.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
1139 |
| Raloxifene |
EU/1/98/073/002 |
EVISTA, Film coated tablet, 60, mg, Pack: 28 |
Daiichi Sankyo Europe GmbH, Германия |
Lilly S.A. - Испания |
20.16 |
4.03 |
24.19 |
6% |
1.21 |
21.37 |
4.27 |
25.64 |
18% |
3.63 |
25 |
5 |
30 |
цената е заличена с решение НСР-7956/08.02.2016 година (в сила от 02.04.2016 година) |
НСР-5401/07.01.2015 |
21.01.2015 |
21.01.2015 |
Заличен |
3486 |
| Raloxifene |
EU/1/98/073/002 |
EVISTA, Film coated tablet, 60, mg, Pack: 28 |
Daiichi Sankyo Europe GmbH, Германия |
Lilly S.A. - Испания |
21.91 |
4.38 |
26.29 |
6% |
1.31 |
23.22 |
4.64 |
27.86 |
18% |
3.94 |
27.16 |
5.43 |
32.59 |
|
НСР-3287/24.04.2014 |
09.05.2014 |
09.05.2014 |
Неактивен |
3486 |
| Raloxifene |
EU/1/98/073/002 |
EVISTA, Film coated tablet, 60, mg, Pack: 28 |
Daiichi Sankyo Europe GmbH, Германия |
Lilly S.A. - Испания |
24.41 |
4.88 |
29.29 |
6% |
1.46 |
25.87 |
5.17 |
31.04 |
18% |
4.39 |
30.26 |
6.05 |
36.31 |
|
НСР-1666/11.11.2013 |
02.04.2014 |
02.04.2014 |
Неактивен |
3486 |
| Raloxifene |
EU/1/98/073/002 |
EVISTA, Film coated tablet, 60, mg, Pack: 28 |
Daiichi Sankyo Europe GmbH, Германия |
Lilly S.A. - Испания |
25.86 |
5.17 |
31.03 |
6% |
1.55 |
27.41 |
5.48 |
32.89 |
18% |
4.65 |
32.06 |
6.41 |
38.47 |
|
КЦРР-675/30.05.2012 г |
20.02.2013 |
20.02.2013 |
Неактивен |
3486 |
| Raloxifene |
EU/1/98/073/002 |
EVISTA, Film coated tablet, 60, mg, Pack: 28 |
Daiichi Sankyo Europe GmbH, Германия |
Lilly S.A. - Испания |
40.52 |
8.1 |
48.62 |
4% |
1.62 |
42.14 |
8.43 |
50.57 |
16% |
6.48 |
48.62 |
9.72 |
58.34 |
|
КЦ-1373/12.02.2010 |
09.03.2010 |
09.03.2010 |
Неактивен |
3486 |
| Clofarabine |
ЕU/1/06/334/005 |
EVOLTRA, Concentrate for solution for infusion, 1 mg/ml - 20 ml, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., UK |
2653.4 |
530.68 |
3184.08 |
4% |
10 |
2663.4 |
532.68 |
3196.08 |
16% |
25 |
2688.4 |
537.68 |
3226.08 |
|
НСР-8342/26.02.2016 |
16.03.2016 |
16.03.2016 |
Активен |
2834 |
| Clofarabine |
ЕU/1/06/334/005 |
EVOLTRA, Concentrate for solution for infusion, 1 mg/ml - 20 ml, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., UK |
2653.57 |
530.71 |
3184.28 |
4% |
10 |
2663.57 |
532.71 |
3196.28 |
16% |
25 |
2688.57 |
537.71 |
3226.28 |
промяна на обстоятелства НСР-4010/30.06.2014 |
НСР-3593/23.05.2014 |
06.06.2014 |
06.06.2014 |
Неактивен |
2834 |
| Clofarabine |
ЕU/1/06/334/005 |
EVOLTRA, Concentrate for solution for infusion, 1 mg/ml - 20 ml, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Penn Pharmaceutical Services Limited; Великобритания; Pharmachemie B.V (PCH) - Холандия |
2900.07 |
580.01 |
3480.08 |
4% |
10 |
2910.07 |
582.01 |
3492.08 |
16% |
25 |
2935.07 |
587.01 |
3522.08 |
|
КЦРР-2057/24.01.2013 |
21.03.2013 |
21.03.2013 |
Неактивен |
2834 |
| Clofarabine |
ЕU/1/06/334/005 |
EVOLTRA, Concentrate for solution for infusion, 1 mg/ml - 20 ml, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Penn Pharmaceutical Services Limited; Великобритания; Pharmachemie B.V (PCH) - Холандия |
3074.45 |
614.89 |
3689.34 |
4% |
10 |
3084.45 |
616.89 |
3701.34 |
16% |
25 |
3109.45 |
621.89 |
3731.34 |
|
КЦ-1728/09.09.2010 |
07.10.2010 |
07.10.2010 |
Неактивен |
2834 |
| Fexofenadine |
20080054 |
Ewofex, Film coated tablet, 120, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
3.56 |
0.71 |
4.27 |
7% |
0.25 |
3.81 |
0.76 |
4.57 |
20% |
0.71 |
4.52 |
0.9 |
5.42 |
|
HCP-9324/16.05.2016 |
02.07.2016 |
02.07.2016 |
Заличен |
1237 |
| Fexofenadine |
II-1925/ 15.04.2008 |
Ewofex, Film coated tablet, 120 mg, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
3.56 |
0.71 |
4.27 |
7% |
0.25 |
3.81 |
0.76 |
4.57 |
20% |
0.71 |
4.52 |
0.9 |
5.42 |
|
КЦРР-730/07.06.2012 |
16.07.2012 |
16.07.2012 |
Неактивен |
1237 |
| Fexofenadine |
20080055 |
Ewofex, Film coated tablet, 180, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
5.34 |
1.07 |
6.41 |
7% |
0.37 |
5.71 |
1.14 |
6.85 |
20% |
1.07 |
6.78 |
1.36 |
8.14 |
|
HCP-9325/16.05.2016 |
02.07.2016 |
02.07.2016 |
Заличен |
1238 |
| Fexofenadine |
II-1926/ 15.04.2008 |
Ewofex, Film coated tablet, 180 mg, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
5.34 |
1.07 |
6.41 |
7% |
0.37 |
5.71 |
1.14 |
6.85 |
20% |
1.07 |
6.78 |
1.36 |
8.14 |
|
КЦРР-730/07.06.2012 |
16.07.2012 |
16.07.2012 |
Неактивен |
1238 |
| Fexofenadine |
II-1926/15.04.2008 |
Ewofex, Film coated tablet, 180 mg, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
6.28 |
1.26 |
7.54 |
9% |
0.57 |
6.85 |
1.37 |
8.22 |
22% |
1.38 |
8.23 |
1.65 |
9.88 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
1238 |
| Fexofenadine |
II-1925/15.04.2008 |
Ewofex, Film coated tablet, 120 mg, mg, Pack: 10 |
Ewopharma International s.r.o., Словакия |
Chanelle Medical, Ireland |
4.09 |
0.82 |
4.91 |
9% |
0.37 |
4.46 |
0.89 |
5.35 |
22% |
0.9 |
5.36 |
1.07 |
6.43 |
|
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Неактивен |
1237 |
| Clozapine |
20130105 |
EXCLOZA, Tablet, 100, mg, Pack: 50 |
Alvogen IPCo S.àr.l, Люксембург |
Synthon BV, Microweg Нидерландия; Synthon Hispania, Испания; S. C. Labormed-Pharma SA, Румъния |
21.3 |
4.26 |
25.56 |
6% |
1.28 |
22.58 |
4.52 |
27.1 |
18% |
3.83 |
26.41 |
5.28 |
31.69 |
промяна на обстоятелства НСР-4385/07.08.2014 |
HCР-489/11.07.2013. |
29.07.2013 |
29.07.2013 |
Активен |
1914 |
| Exemestane |
ІІ -10088/ 24.06.2010 г. |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Великобритания |
27.44 |
5.49 |
32.93 |
6% |
1.65 |
29.09 |
5.82 |
34.91 |
18% |
4.94 |
34.03 |
6.81 |
40.84 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-138/06.04.2015 |
НСР-4145/23.07.2014; НСР-9837/21.07.2016 |
02.09.2016 |
02.09.2016 |
Активен |
3735 |
| Exemestane |
ІІ -10088/ 24.06.2010 г. |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Великобритания |
35.2 |
7.04 |
42.24 |
4% |
1.41 |
36.61 |
7.32 |
43.93 |
16% |
5.63 |
42.24 |
8.45 |
50.69 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-138/06.04.2015 |
НСР-4145/23.07.2014 |
02.05.2015 |
02.05.2015 |
Неактивен |
3735 |
| Exemestane |
ІІ -10088/ 24.06.2010 г. |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Великобритания |
35.52 |
7.1 |
42.62 |
4% |
1.42 |
36.94 |
7.39 |
44.33 |
16% |
5.68 |
42.62 |
8.52 |
51.14 |
|
КЦРР-2310/20.02.2013 |
11.04.2013 |
11.04.2013 |
Неактивен |
3735 |
| Exemestane |
ІІ -10088/ 24.06.2010 |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited Великобритания |
84.06 |
16.81 |
100.87 |
4% |
3.36 |
87.42 |
17.48 |
104.9 |
16% |
13.45 |
100.87 |
20.17 |
121.04 |
|
КЦРР-497/19.04.2012 |
06.06.2012 |
06.06.2012 |
Неактивен |
3735 |
| Exemestane |
№ ІІ - 10088/24.06.2010 |
EXEMESTANE ACCORD, Film coated tablet, 25, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited Великобритания |
101.7 |
20.34 |
122.04 |
6% |
6.1 |
107.8 |
21.56 |
129.36 |
18% |
18.31 |
126.11 |
25.22 |
151.33 |
|
КЦ-1968/26.01.2011 |
11.02.2011 |
11.02.2011 |
Неактивен |
3735 |
| Exemestane |
20100665 |
EXEMESTANE ACTAVIS, Film coated tablet, 25, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
S.C. Sindan – Pharma SRL, Румъния |
35.2 |
7.04 |
42.24 |
4% |
1.41 |
36.61 |
7.32 |
43.93 |
16% |
5.63 |
42.24 |
8.45 |
50.69 |
цената е заличена с решение НСР-6475/18.06.2015 (в сила от 16.07.2015 ) |
НСР-2629/03.02.2014 |
18.02.2014 |
18.02.2014 |
Заличен |
2498 |
| Exemestane |
20100665/ 20.10.2010г. |
EXEMESTANE ACTAVIS, Film coated tablet, 25, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
S.C. Sindan – Pharma SRL, Румъния |
35.52 |
7.1 |
42.62 |
4% |
1.42 |
36.94 |
7.39 |
44.33 |
16% |
5.68 |
42.62 |
8.52 |
51.14 |
|
КЦРР-2458/27.02.2013 |
14.03.2013 |
14.03.2013 |
Неактивен |
2498 |